...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction.
【24h】

Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction.

机译:在急性期反应期间,通过凝结速率和凝结性测定法确定的纤维蛋白原浓度之间存在差异。

获取原文
获取原文并翻译 | 示例
           

摘要

Assays based on clotting rate are commonly used as a routine method for determining the fibrinogen concentration in plasma. However, little is known about the influence of the acute-phase reaction on this assay. In order to disclose discrepancies between the fibrinogen concentrations obtained by a clotting rate assay (as described by Clauss) and a reference assay for total clottable protein (according to Jacobsson), we compared the fibrinogen concentrations determined by these two methods in plasma-samples collected preoperatively and on postoperative days 1, 3, and 5 in patients undergoing major elective surgery. The HMW (High Molecular Weight)-, LMW- and LMW'-fibrinogen fractions of the patient samples were also determined. In preoperative samples, good agreement between the two assays was found. In samples collected on postoperative days 1 and 3, the fibrinogen concentrations measured with the clotting rate assay were significantly higher than the concentrations measured with the total clottable protein assay (p=0.015 on both days). SDS-gel electrophoresis showed an increase in the median HMW-fraction from 69.7% (range 64.3-70.4) in preoperative samples to 85.8% (80.7-87.6) in samples drawn on day 3. The difference between fibrinogen concentrations obtained by the two methods was significantly correlated to the HMW-fraction of the samples. We conclude that during an acute-phase reaction, fibrinogen concentrations obtained by a clotting rate assay (as described by Clauss) are significantly higher than those measured by a total clottable protein assay (according to Jacobsson). The difference between the two methods correlates well with the relative HMW-fraction, indicating that the increase in HMW-fibrinogen is the main contributor to the observed discrepancy.
机译:基于凝血速率的测定通常用作确定血浆中纤维蛋白原浓度的常规方法。但是,关于急性期反应对该测定的影响知之甚少。为了揭示通过凝结速率测定法(如Clauss所述)获得的纤维蛋白原浓度与总可凝结蛋白的参考测定法(根据Jacobsson)之间的差异,我们比较了这两种方法在收集的血浆样本中测定的纤维蛋白原浓度接受大手术的患者在术前和术后第1、3和5天。还确定了患者样品的HMW(高分子量)-,LMW-和LMW'-纤维蛋白原部分。在术前样品中,发现两种测定法之间具有良好的一致性。在术后第1天和第3天收集的样品中,用凝结速率测定法测定的纤维蛋白原浓度显着高于用总可凝结蛋白质测定法测定的浓度(两天均为p = 0.015)。 SDS凝胶电泳显示,术前样品的中位数HMW分数从术前样品的69.7%(范围64.3-70.4)增加到第3天抽取的样品的85.8%(80.7-87.6)。两种方法获得的纤维蛋白原浓度之间的差异与样品的HMW分数显着相关。我们得出结论,在急性期反应期间,通过凝血速率测定法(如Clauss所述)获得的纤维蛋白原浓度明显高于通过总可凝结蛋白质测定法(根据Jacobsson)测得的浓度。两种方法之间的差异与相对HMW分数有很好的相关性,表明HMW纤维蛋白原的增加是观察到差异的主要原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号